國立虎尾科技大學 |

Differential Profiling for Metabolomics and Glycomics by Mass Spectrometry.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Differential Profiling for Metabolomics and Glycomics by Mass Spectrometry./
作者:	Wang, Ziyu.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2022,
面頁冊數:	205 p.
附註:	Source: Dissertations Abstracts International, Volume: 84-05, Section: B.
Contained By:	Dissertations Abstracts International84-05B.
標題:	Analytical chemistry. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29398966
ISBN:	9798352954614

Differential Profiling for Metabolomics and Glycomics by Mass Spectrometry.
Wang, Ziyu.

Differential Profiling for Metabolomics and Glycomics by Mass Spectrometry. - Ann Arbor : ProQuest Dissertations & Theses, 2022 - 205 p.

Source: Dissertations Abstracts International, Volume: 84-05, Section: B.

Thesis (Ph.D.)--Indiana University, 2022.

This item must not be sold to any third party vendors.

Mass spectrometry-based techniques have been widely applied to the characterization of numerous chemical entities as methods to diagnose disease. In a first project, we are studying glycomics and how glycosylation changes with disease state. Previous studies have shown an association of aberrant glycosylation with cancers and autoimmune and inflammatory diseases. With matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS), we have profiled N- and O-glycans derived from human urinary exosomes and have quantified differences between patients with prostate cancer and disease-free individuals. We have also used liquid chromatography-mass spectrometry (LC-MS) to enrich and characterize the structures of sulfated N-glycans derived from human urinary exosomes. In a second project, we are studying metabolomics and how the metabolome of various organisms’ changes during exposure to toxicants. The metabolome represents a molecular phenotype within organisms and changes when exposed to the local environment, which may, in turn, lead to diseases, such as cancers and obesity. We have used direct-infusion mass spectrometry (DI-MS) to analyze metabolites derived from several organisms, including fruit flies and zebrafish, that have been exposed to higher concentration of arsenic. Changes in the metabolome have been tracked over multiple time points and concentrations of arsenic and compared among organisms. In both studies, we have evaluated the molecular compositions and structures of glycans and metabolites with MS techniques and qualitatively and quantitatively assessed how they change due to disease state and exposure to better understand the mechanisms of disease progression.

ISBN: 9798352954614Subjects--Topical Terms:

1182118
Analytical chemistry.
Subjects--Index Terms:

Mass spectrometry

Differential Profiling for Metabolomics and Glycomics by Mass Spectrometry.
LDR:02817nam a2200349 4500 001 1104669
005 20230619080115.5
006 m o d
007 cr#unu||||||||
008 230907s2022 ||||||||||||||||| ||eng d
020 $a 9798352954614
035 $a (MiAaPQ)AAI29398966
035 $a AAI29398966
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wang, Ziyu. $3 1413613
245 1 0 $a Differential Profiling for Metabolomics and Glycomics by Mass Spectrometry.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2022
300 $a 205 p.
500 $a Source: Dissertations Abstracts International, Volume: 84-05, Section: B.
500 $a Advisor: Jacobson, Stephen C.
502 $a Thesis (Ph.D.)--Indiana University, 2022.
506 $a This item must not be sold to any third party vendors.
520 $a Mass spectrometry-based techniques have been widely applied to the characterization of numerous chemical entities as methods to diagnose disease. In a first project, we are studying glycomics and how glycosylation changes with disease state. Previous studies have shown an association of aberrant glycosylation with cancers and autoimmune and inflammatory diseases. With matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS), we have profiled N- and O-glycans derived from human urinary exosomes and have quantified differences between patients with prostate cancer and disease-free individuals. We have also used liquid chromatography-mass spectrometry (LC-MS) to enrich and characterize the structures of sulfated N-glycans derived from human urinary exosomes. In a second project, we are studying metabolomics and how the metabolome of various organisms’ changes during exposure to toxicants. The metabolome represents a molecular phenotype within organisms and changes when exposed to the local environment, which may, in turn, lead to diseases, such as cancers and obesity. We have used direct-infusion mass spectrometry (DI-MS) to analyze metabolites derived from several organisms, including fruit flies and zebrafish, that have been exposed to higher concentration of arsenic. Changes in the metabolome have been tracked over multiple time points and concentrations of arsenic and compared among organisms. In both studies, we have evaluated the molecular compositions and structures of glycans and metabolites with MS techniques and qualitatively and quantitatively assessed how they change due to disease state and exposure to better understand the mechanisms of disease progression.
590 $a School code: 0093.
650 4 $a Analytical chemistry. $3 1182118
653 $a Mass spectrometry
653 $a Glycomics
653 $a Glycosylation
690 $a 0486
710 2 $a Indiana University. $b Chemistry. $3 1192664
773 0 $t Dissertations Abstracts International $g 84-05B.
790 $a 0093
791 $a Ph.D.
792 $a 2022
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29398966